Skip to main content

Advertisement

Log in

Crystal Structure of Ozagrel Fumarate dihydrate (Ozagrel = (E)-3-[4-(1H-imidiazol-1-ylmethyl)phenyl]-2-propenic acid)

  • Original Paper
  • Published:
Journal of Chemical Crystallography Aims and scope Submit manuscript

Abstract

Ozagrel, (E)-3-[4-(1H-imidiazol-1-ylmethyl)phenyl]-2-propenic acid, crystallizes with fumaric acid in absolute ethanol to give the dihydrous fumarate salt, [(C13H13N2O2)2]2+ [C4H2O4]2−·2H2O, which crystallizes in the monoclinic space group P2(1)/n with a = 4.7981(19), b = 11.101(6), c = 26.930(11) Å, β = 90.567(16)°, V = 1434.3(11) Å3, Z = 4, C15H16N2O5, M r  = 304.30, D c  = 1.409 g/cm3. In the crystal structure, fumaric acid transfers two protons to imidazole ring N atoms of ozagrel. And the resulting carboxylate anions are simultaneously hydrogen-boned to carboxylic group and imidazole ring of ozagrel to give rise to a 2D layer structure. Hydrogen-bonding interactions between water and fumarate dianion result in a 3D structure.

Graphical Abstract

Ozagrel crystallizes with fumaric acid in absolute ethanol to give the dihydrous fumarate salt in which fumaric acid transfers two protons to imidazole ring N atoms of ozagrel and the resulting carboxylate anions are simultaneously hydrogen-boned to carboxylic group and imidazole ring of ozagrel to give rise to a 2D layer structure. Hydrogen-bonding interactions between water and fumarate dianion result in a 3D structure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Scheme 1
Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Vippagunta SR, Brittain HG, Grant DJW (2001) Adv Drug Deliv Rev 48:3–26

    Article  CAS  Google Scholar 

  2. Almarsson Ö, Zaworotko MJ (2004) Chem Commun (Camb) 1889–1896

  3. Childs LS, Stahly GP, Park A (2007) Mole Pharm 4:323–328

    Article  CAS  Google Scholar 

  4. Black SN, Collier E, Davey RJ, Roberts RJ (2007) J Pharm Sci 96:1053–1068

    Article  CAS  Google Scholar 

  5. Basavoju S, Boström D, Velaga SP (2006) Cryst Growth Des 6:2699–2708

    Article  CAS  Google Scholar 

  6. Kato H, Emura S, Takeuchi N, Enoki M, Oogushi K, Takashima T, Ohmori K, Saito I (1997) J Int Med Res 25:108–111

    CAS  Google Scholar 

  7. Yang WC, Ju CC, Fan SH, Sun HL, Wang KZ (2008) Acta Phys—Chim Sin 24:176–178

    CAS  Google Scholar 

  8. Wang YT, Tang GM, Liu ZM, Yi XH (2007) Cryst Growth Des 7:2272–2275

    Article  CAS  Google Scholar 

  9. Morita K, Yamakawa M, Minouchi T, Hayashi Y, Hoshino N, Konishi H, Ono T, Shimakawa H (1989) Chem Pharm Bull 37:3351–3354

    CAS  Google Scholar 

  10. Molecular Structure Corporation (1999) TEXRAY and TEXSAN, Versions 1.10. MSC. The Woodlands, USA

    Google Scholar 

  11. Sheldrick GM (1997) SHELXS-97, Crystal structure solution. University of Göttingen, Göttingen

    Google Scholar 

  12. Sheldrick GM (1997) SHELXL-97 Crystal Structure Refinement. University of Göttingen, Göttingen

    Google Scholar 

Download references

Acknowledgments

The authors acknowledge the supports from the Project of the Natural Science Foundation of Fujian Province, China (2008J0164), the Special Foundation for Young Scientists of Fujian Province (2008F3081) and the Project from Fuzhou Municipal Bureau of Science and Technology (2007-Z-81).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Benyong Lou.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lou, B., Guo, X., Lin, Q. et al. Crystal Structure of Ozagrel Fumarate dihydrate (Ozagrel = (E)-3-[4-(1H-imidiazol-1-ylmethyl)phenyl]-2-propenic acid). J Chem Crystallogr 39, 831–834 (2009). https://doi.org/10.1007/s10870-009-9590-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10870-009-9590-4

Keywords

Navigation